Lncap

WikiDoc Resources for Lncap
Articles
Most recent articles on Lncap Most cited articles on Lncap Review articles on Lncap Articles on Lncap in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Lncap Images of Lncap Photos of Lncap Podcasts & MP3s on Lncap Videos on Lncap
Evidence Based Medicine
Cochrane Collaboration on Lncap Bandolier on Lncap TRIP on Lncap
Clinical Trials
Ongoing Trials on Lncap at Clinical Trials.gov Trial results on Lncap Clinical Trials on Lncap at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Lncap NICE Guidance on Lncap NHS PRODIGY Guidance FDA on Lncap CDC on Lncap
Books
Books on Lncap
News
Lncap in the news Be alerted to news on Lncap News trends on Lncap
Commentary
Blogs on Lncap
Definitions
Definitions of Lncap
Patient Resources / Community
Patient resources on Lncap Discussion groups on Lncap Patient Handouts on Lncap Directions to Hospitals Treating Lncap Risk calculators and risk factors for Lncap
Healthcare Provider Resources
Symptoms of Lncap Causes & Risk Factors for Lncap Diagnostic studies for Lncap Treatment of Lncap
Continuing Medical Education (CME)
CME Programs on Lncap
International
Lncap en Espanol Lncap en Francais
Business
Lncap in the Marketplace Patents on Lncap
Experimental / Informatics
List of terms related to Lncap

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

LNCaP cells are androgen-sensitive human prostate adenocarcinoma cells derived from the left supraclavicular lymph node metastasis from a 50-year-old caucasian male in 1977. LNCap cells are commonly used in the field of oncology. They are adherent epithelial cells growing in aggregates and as single cells.

The LNCaP cell line was established from a metastatic lesion of human prostatic adenocarcinoma. The LNCaP cells grow readily in vitro (up to 8 x 10(5) cells/sq cm; doubling time, 60 hr), form clones in semisolid media, are highly resistant to human fibroblast interferon, and show an aneuploid (modal number, 76 to 91) human male karyotype with several marker chromosomes. The malignant properties of LNCaP cells are maintained. Athymic nude mice develop tumors at the injection site (volume-doubling time, 86 hr). Functional differentiation is preserved; both cultures and tumor produce acid phosphatase. High-affinity specific androgen receptors are present in the cytosol and nuclear fractions of cells in culture and in tumors. Estrogen receptors are demonstrable in the cytosol. The model is hormonally responsive. In vitro, 5 alpha-dihydrotestosterone modulates cell growth and stimulates acid phosphatase production. The cell line does express PSA (Prostate Specific Antigen). In vivo, the frequency of tumor development and the mean time of tumor appearance are significantly different for either sex. Male mice develop tumors earlier and at a greater frequency than do females. Hormonal manipulations show that, regardless of sex, the frequency of tumor development correlates with serum androgen levels. The rate of the tumor growth, however, is independent of the gender of hormonal status of the host.